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Background: Practice guidelines for PCI were published by the ESC in 2005. Little is known about the current use of PCI for the different 
indications of ACS and stable angina in daily practice in Europe.
Methods: Between 2005 and 2008, consecutive patients undergoing PCI were enrolled into the PCI-Registry of the Euro Heart Survey Programme 
to document patient characteristics, PCI details and hospital complications in different PCI indications.
Results: A total of 47,409 consecutive patients undergoing PCI were enrolled in 176 centres in 33 member countries of the ESC. Primary PCI in 
STEMI was performed in 17.1%, PCI in stabilised STEMI (> 72 h post MI) in 5.8%, PCI for NSTEMI in 13.1%, for unstable angina in 15.4% and for 
stable angina (elective PCI) in 48.5%. Patient characteristics, treatment details and hospital complications are displayed in the table.
Conclusion: More than half of the PCI in clinical practice in Europe were performed in patients presenting with ACS. Drug eluting stents were 
used in 46.0% of the patients with a higher rate in elective PCI as compared to PCI for any ACS. Hospital mortality was 5.2% in patients undergoing 
primary PCI for STEMI, very similar to that reported in randomised controlled trials. Hospital mortality in PCI for any other indication was low as were 
the rates for MI, stroke and bleeding complications. 
STEMI
n=8,104
Post STEMI
n=2,765
NSTEMI
n=6,202
UA
n=7,324
Elective
n=23,014
Age [years] / >75y [%] 62 / 18.7 62 / 14.6 66 / 24.3 65 / 20.7 64 / 14.7
Female Gender 26.3 % 23.5 % 28.6 % 26.5 % 24.9 %
Prior MI 16.9 % 28.8 % 28.8 % 34.0 % 41.1 %
Prior PCI 10.3 % 8.3 % 15.4 % 28.7 % 31.5 %
Diabetes mellitus 19.7 % 25.0 % 26.4 % 27.3 % 25.7 %
3-Vessel-Disease 23.4 % 18.1 % 28.9 % 24.0 % 18.1 %
In-Stent-Stenosis 3.5 % 1.8 % 3.5 % 7.0 % 6.1 %
Stent implanted 89.9 % 92.8 % 90.3 % 89.2 % 90.5 %
Drug Eluting Stents 35.5 % 42.3 % 45.6 % 46.2 % 49.8 %
Thrombus aspiration 12.6 % 1.4 % 2.6 % 0.4 % 0.1 %
GP IIb/IIIa 51.3 % 21.0 % 28.1 % 19.1 % 16.7 %
LMW-Heparin 23.1 % 36.8 % 39.4 % 32.7 % 21.2 %
Hospital MI 3.4 % 1.5 % 1.8 % 1.5 % 0.7 %
Hospital Stroke 0.5 % 0.3 % 0.3 % 0.3 % 0.1 %
Major Bleeding 1.5 % 0.7 & 1.1 % 0.6 % 0.4 %
Hospital Mortality 5.2 % 0.8 % 1.9 % 0.5 % 0.2 %
